DocSym
β
Searchsearch
Search
(P58.3) Neonatal jaundice due to polycythaemia
More details coming soon
675 518 in individuals diagnosis neonatal jaundice due to polycythaemia confirmed
Diagnosis neonatal jaundice due to polycythaemia is diagnosed Men are 13.21% more likely than Women
382 373
Men receive the diagnosis neonatal jaundice due to polycythaemia
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
293 145
Women receive the diagnosis neonatal jaundice due to polycythaemia
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease neonatal jaundice due to polycythaemia - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 0-19, 25-34, 40-95+
In Women diagnosis is most often set at age 0-1, 20-24, 35-39
Disease Features neonatal jaundice due to polycythaemia
Absence or low individual and public risk
Neonatal jaundice due to polycythaemia - what does this mean
Neonatal jaundice due to polycythaemia is caused by an overproduction of red blood cells in the newborn, leading to an excess of bilirubin in the bloodstream. this causes the newborn's skin to become yellow due to the accumulation of bilirubin in the tissues. in severe cases, it can cause brain damage if left untreated.
What happens during the disease - neonatal jaundice due to polycythaemia
Neonatal jaundice due to polycythaemia is a condition where the newborn has an abnormally high concentration of red blood cells, resulting in an accumulation of bilirubin in the body which causes the skin and eyes to appear yellow. this is often due to a genetic disorder or an inherited condition, such as a blood disorder, or an infection that affects the production of red blood cells. in some cases, the newborn's body may be unable to process the excess red blood cells, resulting in an accumulation of bilirubin in the body which causes the skin and eyes to appear yellow. the exact cause of polycythaemia in newborns is unknown, but it is believed to be related to the mother's health during pregnancy.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC) to measure the number of red blood cells
- Blood smear to check the size and shape of red blood cells
- Blood gas analysis to measure oxygen levels
- Urine analysis to check for bilirubin levels
- Liver function tests to assess bile production
- Ultrasound to check for any structural abnormalities of the liver or spleen
Treatment and Medical Assistance
Main Goal: To reduce the levels of bilirubin and improve the condition of the newborn
- Administer phototherapy to reduce bilirubin levels.
- Perform exchange transfusion to reduce the number of red blood cells.
- Provide supportive care to maintain hydration and nutrition.
- Monitor the newborn’s hemoglobin levels regularly.
- Monitor the newborn’s bilirubin levels regularly.
- Administer medications to reduce red blood cell production.
- Administer albumin to reduce the risk of bilirubin toxicity.
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Neonatal jaundice due to polycythaemia - Prevention
Neonatal jaundice due to polycythaemia can be prevented by monitoring the newborn's hemoglobin levels and by ensuring that the newborn is adequately hydrated. it is also important to ensure that the newborn is not exposed to too much light and that the mother's diet is well balanced to prevent an excessive increase in the newborn's hemoglobin levels.